Search

everythinglearnresearchcommunity

for

Search:↓

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Low level laser therapy works best for hair loss, followed by PRP, finasteride, and minoxidil.

Antidepressants, 5α-reductase inhibitors, and isotretinoin can cause long-lasting sexual dysfunction.

DHT, a testosterone byproduct, causes male pattern baldness.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Certain drugs that block specific enzymes can help treat prostate diseases.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Tamoxifen effectively treats gynecomastia without causing impotence.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Thyrotropin-Releasing Hormone helps heal wounds in frog and human skin.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Quercetin may help with PCOS symptoms, but more research is needed.

Dutasteride-containing mesotherapy effectively treats female hair loss, improving density and thickness with minimal side effects.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.